Description
Imfinzi 500mg available with us.
Durvalumab is an FDA-approved immunotherapy for cancer, developed by Medimmune. It is a human immunoglobulin G1 kappa monoclonal antibody that blocks the interaction of programmed cell death ligand 1 with the PD-1.
| Composition | durvalumab |
| Packaging Type | vial |
| Dose/Strength | 500mg |
| Dosage Form | 500mg |
| Form of Medicine | injection |
| Brand | Durvalumab |
Reviews
There are no reviews yet.